jueves, 6 de marzo de 2025

Tislelizumab Receives First-Line Nod for Unresectable/Metastatic ESCC M. Alexander Otto, PA, MMS March 05, 2025

https://www.medscape.com/viewarticle/tislelizumab-receives-first-line-nod-unresectable-metastatic-2025a10005eq

No hay comentarios:

Publicar un comentario